A Phase I Study of Convection-Enhanced Delivery of 124I-8H9 for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy.

Trial Profile

A Phase I Study of Convection-Enhanced Delivery of 124I-8H9 for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 02 Jun 2017

At a glance

  • Drugs Monoclonal antibody 8H9-I-124 (Primary)
  • Indications Brain cancer; Glioma
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Jun 2017 Results (n=25) presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
    • 06 Apr 2017 Planned number of patients changed from 66 to 64.
    • 22 Feb 2017 Planned number of patients changed from 28 to 66.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top